Veracyte, Inc. (Nasdaq: VCYT), a leading genomic diagnostics company, announced today that the first prospective validation data for a molecular signature to predict hormone therapy benefit in men ...
(Nasdaq: VCYT), a leading genomic diagnostics company, announced that new data from the prospective, randomized integral biomarker BALANCE trial (NCT03371719) finds that the PAM50 molecular signature ...
Inocras, a bioinformatics-led company harnessing the power of whole genome data and proprietary analytics to deliver curated insights that advance precision health, in collaboration with the Lee ...
Samples from Spanish supercentenarian María Branyas Morera reveal the keys to her exceptional genetics and provide clues for ...
News Commentary Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, Sept. 25, 2025 /CNW/ — America’s aging demographics are creating unprecedented demand for precision ...
This work presents valuable new data on the role of D-Serine and how it competes with its stereoisomer L-Serine to influence metabolism. The work presents a variety of solid experimental data combined ...
David Ussery discuss work using high-performance computing for the analysis of millions of viral genome sequences ...
Introduction Chronic caregiving stress accelerates biological aging, reflecting disease risk and mortality; however, the ...
This valuable study analyzes aging-related chromatin changes through the lens of intra-chromosomal gene correlation length, which is a novel computational metric that captures spatial correlations in ...
Qigong, a type of mind-body exercise, has been adopted by some patients with cancer to improve their QoL. However, various lengthy questionnaires were used to assess Qigong’s effects which made data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback